Skip to main content
Back to Octopus Ventures

Octopus Ventures's Pharmaceutical Portfolio

Browse 4 Pharmaceutical companies funded by Octopus Ventures. See funding amounts, founder contacts, and investment details.

Pharmaceutical Companies
4
Total Funding in Pharmaceutical
$60.5M

Pharmaceutical Portfolio Companies (4)

Export
Artificial Intelligence (AI)Machine LearningPharmaceuticalSoftware

PeakData is a software platform to identify and analyze key opinion leaders in your therapeutic area.

Zug, Switzerland
August 2022
$12.4M
Series A

Founder Contacts

30,000+ verified contacts

Health CarePharmaceuticalTherapeutics

Skin + Me is a D2C brand providing personalized skin treatments for feel-great skin.

London, United Kingdom
February 2023
$12.0M
Series B

Founder Contacts

30,000+ verified contacts

ChemicalManufacturingPharmaceutical

DUDE CHEM is a leading company in green chemical manufacturing based in Berlin.

Berlin, Germany
February 2024
$7.0M
Seed

Founder Contacts

30,000+ verified contacts

Clinical TrialsHealth CareMedicalPharmaceutical

myTomorrows is a global platform that connects patients with unmet medical needs to treatments in development around the world.

Amsterdam, The Netherlands
November 2025
$29.0M
Private Equity

Founder Contacts

30,000+ verified contacts

Explore Octopus Ventures's Full Portfolio

View all companies funded by Octopus Ventures across every industry and funding stage.

View Full Octopus Ventures Portfolio